ReviewHeliyon2023

Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis.

Qin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.